 NEW YORK, March 22, 2021 PRNewswire -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Intec Pharma Ltd. Intec or the Company NASDAQ: NTEC in connection with the proposed acquisition of the Company by Decoy Biosystems, Inc.Decoy. 